Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced that Russia has chosen inactivated polio vaccine (IPV) from Sanofi Pasteur for primary immunization of all infants. The IPV do
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Over the past year, physician visitation to customer service portals decreased while interest in using them actually increased. To help biopharma companies bridge the gap between the current portal l
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
The U.S. Food and Drug Administration is warning consumers about a fraudulent scheme to extort money from consumers by callers who falsely identify themselves as "FDA special agents" or other FDA o
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Pfizer today announced the launch of a new research unit known as Pfizer Regenerative Medicine. This independent research unit will build on recent scientific progress in understanding the biology of
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
AstraZeneca has announced that the once-daily formulation SEROQUEL XR (quetiapine fumarate extended release tablets) and SEROQUEL (quetiapine fumarate) have been approved under the European Mutual Re
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
An EU-funded population study has shown that hypertension, an important risk factor for cardiovascular disease, is a serious problem in Europe. The results of the IMMIDIET project indicate that high
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Roche has announced that the SATURN (SequentiAl Tarceva in UnResectable NSCLC) study met its primary endpoint of progression free survival. The study showed that Tarceva (erlotinib), when given in fi
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
Findings from the ATLAS ACS TIMI 46 study - a Phase II study of the novel oral anticoagulant Xarelto® (rivaroxaban) - were presented as a late-breaking clinical trial at the American Heart Associatio
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
New data from the JUPITER study demonstrated that CRESTOR® (rosuvastatin calcium) 20 mg significantly reduced major cardiovascular (CV) events (defined in this study as the combined risk of myocardia
read more » Discuss Add this link to...Bury Add to:
| Bookmarks
As part of the U.S. Food and Drug Administration's ongoing efforts to ensure that heparin for patients remains safe, the government has seized 11 lots of heparin from Celsus Laboratories Inc. in Cin
read more » Discuss Add this link to...Bury Add to:
| Bookmarks